← Leaderboards
Douglas K Mitchell
Eastern Virginia Medical School
$1,101,565
Attributed
$1,101,565
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,101,565 · 2
By mechanism
R01$1,029,885 · 1
R03$71,680 · 1
Top collaborators
No co-investigators on record.
Most similar at Eastern Virginia Medical School
Same institution · by research overlap
- Xi Jiang$15,222,953
- Guillermo Ruiz-Palacios$2,239,658
- David O Matson$954,928
- E S Buescher$652,488
- David S Newburg$14,172,006
Others in their field
Top investigators on “Antiviral Antibody”
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$103,603,891
- Constance Ann Benson · University Of California, San Diego$99,214,739
- Judith S. Currier · University Of California Los Angeles$99,031,946
- Sharon A Nachman · Johns Hopkins University$74,930,519
- Thomas William Geisbert · Boston University Medical Campus$49,367,123
- Dan H. Barouch · Fred Hutchinson Cancer Center$47,778,582
Research focus
Antiviral AntibodyClinical ResearchDiarrheaEpidemiologyGenetic StrainHuman SubjectRna VirusMexicoMicroorganism Population StudyChild (0-11)United StatesHealth Care Cost /FinancingHumoral ImmunityLongitudinal Human StudyVirus GeneticsOpportunistic InfectionsPathologic ProcessPediatricsPolymerase Chain ReactionPreschool Child (1-5)CapsidProtein SequenceCooperative StudyVirus Infection Mechanism
Grant awards (6)
Hospital-Based Assessment of Human Astrovirus Infection$32,640
R03 · FY2004 · TW
MOLECULAR EPIDEMIOLOGY AND IMPACT OF HUMAN ASTROVIRUSES$269,800
R01 · FY2003 · AI
Hospital-Based Assessment of Human Astrovirus Infection$39,040
R03 · FY2003 · TW
MOLECULAR EPIDEMIOLOGY AND IMPACT OF HUMAN ASTROVIRUSES$229,330
R01 · FY2002 · AI
MOLECULAR EPIDEMIOLOGY AND IMPACT OF HUMAN ASTROVIRUSES$269,800
R01 · FY2001 · AI
MOLECULAR EPIDEMIOLOGY AND IMPACT OF HUMAN ASTROVIRUSES$260,955
R01 · FY2000 · AI